Published in Health Business Week, March 26th, 2004
In the Senate Human Resources Committee, a bill allowing only trace amounts of a mercury-base preservative called thimerosal in childhood vaccinations was approved 9-3.
Senator Ken Veenstra, R-Orange City, who sponsored the bill, said he was concerned about possible links between thimerosal and neurodevelopmental disorders, such as autism, attention deficit hyperactivity disorder and speech or language delay.
According to the U.S. Centers for Disease Control (CDC), studies have not found enough evidence to determine whether or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.